Clinical trial NCT04021095: Novel Head Protection Prototype Device for Decompression Craniectomy
Official title: An Exploratory Study on the Development of a Novel Head Protection Prototype Device for Post-decompression Craniectomy Patients
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Brain Injuries
Stroke
Lead sponsor: Tan Tock Seng Hospital
Sponsor class: OTHER
Collaborators: name: Creatz3D
First posted: 2019-07-16
Enrollment: 10
Sex: ALL
Minimum age (years): 21
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: Customised head protection prototype device.
Primary purpose: OTHER

Brief summary: A proof-of-concept (POC) proposal to study the feasibility of customized head protection prototype device (HPPD) using 3D printed externally-applied moulded skin prosthesis integrated to the craniectomy bony skull defect.

Detailed description: A proof-of-concept (POC) proposal to study the feasibility of customized head protection prototype device (HPPD) using 3D printed externally-applied moulded skin prosthesis integrated to the craniectomy bony skull defect. The proposed material is a bio-compatible, light-weight rigid /semi rigid material which can be fitted to the skull defect and interfaced with the subject's bony rim using soft, deformable material (e.g. silicon) and attached using an elastic head band or other acceptable means. The prosthesis is removable for skin and prosthesis cleansing and ventilation.

Study Specific Objectives:

(i) Primary Objectives

These are to:

1. test the feasibility and safety of customised 3D printed HPPD,
2. integrate the prostheses to the skull defect in removable manner and discharge patient with appropriate education,
3. to systematically monitor subjects for symptoms, compliance, complications and subjective feedback during the outpatient phase where progressive wear of HPPD and monitoring of acceptability will be monitored.

Eligibility criteria: Inclusion Criteria:

All subjects must meet all of the inclusion criteria to participate in this study.

1. Age 21 to 80 years, both males and females.
2. Presence of surgical unilateral or bilateral craniectomy performed for reasons of ischaemic or haemorrhagic stroke, Subarachnoid haemorrhage (SAH), traumatic brain injury (TBI), benign cerebral tumours, etc.
3. Stroke, SAH or TBI are diagnosed by specialists and confirmed on brain imaging studies (CT, MRI)
4. Duration from event \> 30 days and either during inpatient or outpatient phase.
5. Presence of at least 1 post decompressive craniectomy CT brain film performed at NNI/TTSH.
6. Healed craniectomy surgical wound without bulging skin flap or active skin infection.
7. Patients awaiting elective cranioplasty or those who refuse cranioplasty. 8 Ability to understand simple instructions and give own consent. 9 Presence of family members or NOK who can supervise the patient to don the head protection device, care for the material and regularly monitor for compliance and complications 10 Reproductive age females should not be pregnant at the point of consent-taking and during the study

Exclusion Criteria:

1. Patient in vegetative or minimally responsive state.
2. Presence of uncontrolled medical condition (uncontrolled hypertension, Diabetes Mellitus, sepsis or delirium, active malignancy either cranial or extracranial sites)
3. Presence of end organ failure (end stage renal or liver failure, renal dialysis, life expectancy \<6 months)
4. Presence of pregnancy or lactation.
5. Presence of severe agitation /behavioural/active depression or anxiety/ drug or alcohol addiction which would negatively affect compliance,
6. Presence of unhealed head wound, active wound infection, scalp dermatitis, wound breakdown which would be worsened by pressure from the HPPD.
7. Presence of known allergy to the investigational products which is the 3D printed material (e.g. Nylon).
8. Subjects' CT brain imaging films are not available to the study team.
9. Absence of NOK who can assist monitoring unless subjects is able to self-monitor

Primary outcomes:
measure: Percentage of acute complications at second hour of HPPD fitting
timeFrame: 12 months
Secondary outcomes:
measure: Percentage of acute complications at end of first week of HPPD use.
timeFrame: 12 months
Other outcomes:
Locations:
city: Singapore
country: Singapore
facility: Tan Tock Seng Hospital Rehabilitation Centre
Study officials:
affiliation: Tan Tock Seng Hospital Clinical research and innovation office
name: Khai Pang Leong
role: STUDY_DIRECTOR
References: